No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
SCPH240816C5000
- 0.41
- +0.02+5.13%
15min DelayClose Jul 22 16:00 ET
0.41High0.35Low
0.35Open0.39Pre Close38 Volume541 Open Interest5.00Strike Price1.35KTurnover109.24%IV15.85%PremiumAug 16, 2024Expiry Date0.00Intrinsic Value100Multiplier25DDays to Expiry0.41Extrinsic Value100Contract SizeAmericanOptions Type0.4678Delta0.2959Gamma11.39Leverage Ratio-0.0109Theta0.0012Rho5.33Eff Leverage0.0049Vega
Intraday
- 5D
- Daily
News
Craig-Hallum Maintains ScPharmaceuticals(SCPH.US) With Buy Rating
Craig-Hallum analyst Chase Knickerbocker maintains $scPharmaceuticals(SCPH.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 43.5% and a total average return of 2.7%
These 2 'Strong Buy' Penny Stocks Are Poised for a Massive Rally, Say Analysts
ScPharmaceuticals to Present at the Jefferies Global Healthcare Conference
BURLINGTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of
Analysts Have Conflicting Sentiments on These Healthcare Companies: ScPharmaceuticals (SCPH), Andlauer Healthcare Group (OtherANDHF) and Roche Holding AG (OtherRHHVF)
Furoscix Growth Prospects Anchor Buy Rating for ScPharmaceuticals
Analysts Are Bullish on These Healthcare Stocks: ScPharmaceuticals (SCPH), Optinose (OPTN)
Comments
$scPharmaceuticals(SCPH.US$
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
scPharmaceuticals (Nasdaq: SCPH) announced that its CEO, John Tucker, will present at the Jefferies Global Healthcare Conference on June 5, 2024. The presentation will occur at 5:00 PM ET, with Tucker also engaging in meetings with investors throughout the day. The webcast of the presentation will be accessible via the company’s Investor Relations section on its website.
scPharmaceuticals to Present at the Jefferies Global Healthcare Conference
scPharmaceuticals (Nasdaq: SCPH) announced that its CEO, John Tucker, will present at the Jefferies Global Healthcare Conference on June 5, 2024. The presentation will occur at 5:00 PM ET, with Tucker also engaging in meetings with investors throughout the day. The webcast of the presentation will be accessible via the company’s Investor Relations section on its website.
Gainers:
• $Spirit Airlines(SAVE.US$ +15.8% (JetBlue Urges Spirit Shareholders to Protect Their Interests and 'Vote No' on Frontier Transaction at Upcoming Spirit Special Meeting)
• $scPharmaceuticals(SCPH.US$ +14% (announces FDA acceptance of FUR.OSCIX new drug application)
• $Rattler Midstream(RTLR.US$ +12.5% (Diamondback Energy (FANG) agrees to acquire publicly held units of Rattler Midstream)
• $Carvana(CVNA.US$ +12.7% (the u...
• $Spirit Airlines(SAVE.US$ +15.8% (JetBlue Urges Spirit Shareholders to Protect Their Interests and 'Vote No' on Frontier Transaction at Upcoming Spirit Special Meeting)
• $scPharmaceuticals(SCPH.US$ +14% (announces FDA acceptance of FUR.OSCIX new drug application)
• $Rattler Midstream(RTLR.US$ +12.5% (Diamondback Energy (FANG) agrees to acquire publicly held units of Rattler Midstream)
• $Carvana(CVNA.US$ +12.7% (the u...
19
2
Read more